CN113189228B - Method for detecting related substances in terbutaline sulfate - Google Patents

Method for detecting related substances in terbutaline sulfate Download PDF

Info

Publication number
CN113189228B
CN113189228B CN202110453648.4A CN202110453648A CN113189228B CN 113189228 B CN113189228 B CN 113189228B CN 202110453648 A CN202110453648 A CN 202110453648A CN 113189228 B CN113189228 B CN 113189228B
Authority
CN
China
Prior art keywords
mobile phase
ammonium formate
related substances
following
steps
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202110453648.4A
Other languages
Chinese (zh)
Other versions
CN113189228A (en
Inventor
葛志乐
韩冰容
鲁智婷
陈翠翠
罗鸣
黄浩喜
苏忠海
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sichuan Pu Et Pharmaceutical Co ltd
Chengdu Beite Pharmaceutical Co ltd
Original Assignee
Sichuan Pu Et Pharmaceutical Co ltd
Chengdu Beite Pharmaceutical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sichuan Pu Et Pharmaceutical Co ltd, Chengdu Beite Pharmaceutical Co ltd filed Critical Sichuan Pu Et Pharmaceutical Co ltd
Priority to CN202110453648.4A priority Critical patent/CN113189228B/en
Publication of CN113189228A publication Critical patent/CN113189228A/en
Application granted granted Critical
Publication of CN113189228B publication Critical patent/CN113189228B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/06Preparation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/06Preparation
    • G01N2030/065Preparation using different phases to separate parts of sample

Landscapes

  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)

Abstract

The invention provides a method for detecting related substances in terbutaline sulfate, which adopts high performance liquid chromatography for detection. The method can well realize the retention of the strong-polarity impurities and the effective elution of the weak-polarity impurities, and can also reduce the damage of the solvent to chromatographic facilities.

Description

Method for detecting related substances in terbutaline sulfate
Technical Field
The invention relates to a method for detecting related substances in terbutaline sulfate.
Background
Terbutaline sulfate, chemical name (+/-) -alpha- [ (tert-butylamino) methyl ] -3, 5-dihydroxy benzyl alcohol sulfate (2: 1), structural formula as follows, is an adrenergic agonist, can selectively stimulate beta 2-receptor, relax bronchial smooth muscle, inhibit release of endogenous spasmodic substances and edema caused by endogenous mediators, improve the clearance capability of bronchial mucosa ciliated epithelium, and can also relax uterine smooth muscle. The traditional Chinese medicine composition is mainly used for treating bronchial asthma, chronic bronchitis and other lung diseases accompanied with bronchospasm, can also be used for preventing premature delivery and fetal asphyxia, has the characteristics of high selectivity, less side effect and the like, and is widely applied at home and abroad. The strain is currently recorded in China, america, japan, europe, british pharmacopoeia and the like. At present, the preparation mainly comprises terbutaline sulfate tablets, terbutaline sulfate inhalation aerosol and terbutaline sulfate atomized liquid.
Figure BDA0003039701220000011
Terbutaline sulfate structural formula
Terbutaline sulfate is collected in USP, EP, BP, JP and ChP, where the control methods for the relevant substances are essentially identical: the system adopts a mixed solution of a main component and an impurity C to investigate the separation degree, and a mobile phase system adopts an ammonium formate buffer solution containing high-concentration sodium hexanesulfonate and methanol to perform isocratic elution according to the proportion of 77.
However, during the application process, the pharmacopoeia method has the defects that: the isocratic elution mode ensures that the impurities with strong polarity are not retained, and the impurities with weak polarity cannot be completely eluted. In order to take account of the polarity of each impurity, a gradient elution mode is needed, the organic phase ratio is gradually increased in the elution process, but the high-concentration ammonium formate and sodium hexanesulfonate in the mobile phase can be salted out along with the increase of the organic phase ratio, so that the chromatographic column and the instrument are damaged. In other non-pharmacopeial methods, solvents which damage the column, such as triethylamine, are also used to improve the separation.
Disclosure of Invention
The inventor researches to show that: process impurities of widely varying polarity may be produced in the terbutaline sulfate synthesis process, including but not limited to:
Figure BDA0003039701220000012
the isocratic elution mode ensures that the impurities with strong polarity are not retained, and the impurities with weak polarity cannot be completely eluted. In order to better realize the retention of strong polar impurities and the effective elution of weak polar impurities and reduce the damage of a solvent to chromatographic facilities, the invention provides a liquid chromatographic detection method which does not contain ion pair reagents of sodium hexanesulfonate and triethylamine.
Specifically, the invention provides a method for detecting related substances in terbutaline sulfate, wherein the related substances at least comprise TBS4-Z5:
Figure BDA0003039701220000021
the detection is carried out by adopting high performance liquid chromatography, and comprises the following contents:
a chromatographic column: octadecylsilane chemically bonded silica gel column
Mobile phase: the method comprises the following steps of (1) preparing a mobile phase A and a mobile phase B, wherein the mobile phase A is an ammonium formate buffer solution, and the pH value of the mobile phase A is adjusted to 2.5-3.5 by trifluoroacetic acid; the mobile phase B is methanol or/and acetonitrile; the elution procedure was followed with a gradient from 0 to 50 minutes as follows:
Figure BDA0003039701220000022
the size of the chromatographic column can be conventional, the length of the chromatographic column is 50-250 mm, the inner diameter of the chromatographic column is 2.1-4.6 mm, and the particle size of the filler is 3-5 mu m. For example, the length is 250mm, the inner diameter is 4.6mm, and the particle diameter is 5 μm.
Wherein the mobile phase A is an ammonium formate buffer solution, and the concentration of ammonium formate in the buffer solution is 0.04-0.06 mol/L, preferably 0.05mol/L. Taking ammonium formate solution with proper concentration, and adjusting the pH value with trifluoroacetic acid. The pH is 2.5 to 3.5, and further 2.8 to 3.2, for example 3.0, may be selected.
The mobile phase B mainly comprises methanol or/and acetonitrile. Methanol may be predominant.
The column temperature, flow rate, detection wavelength and other parameters of the invention can be selected in common ranges. The detection wavelength is selected from 210-400 nm, specifically 276nm; the flow rate of the mobile phase is selected from 0.8ml/min to 1.2ml/min, and is specifically 1.0ml/min; the column temperature is selected from 38-42 ℃, in particular 40 ℃.
The detection method of the invention also comprises other conventional steps:
(1) Preparing a blank solvent, a system applicability solution and an impurity reference substance solution;
(2) Preparing a test solution, a control solution and a sensitivity solution;
(3) Detecting a test article; and so on.
The experimental result shows that although the ion pair reagents sodium hexanesulfonate and triethylamine are not used in the detection by the method, the strong polar impurities TBS4-Z5 are effectively retained and other impurities are successfully eluted under the condition of ensuring good separation degree of main components and various impurities under the specific mobile phase condition, and the separation degree is good, so that the damage of the solvent to chromatographic facilities in the prior art is effectively avoided.
Based on the good retention and separation effects of the invention on compounds with large polarity difference, the invention also provides a method for simultaneously detecting the following two compounds, wherein the structural formulas of the two compounds are as follows:
Figure BDA0003039701220000031
the detection is carried out by adopting high performance liquid chromatography, and comprises the following contents:
a chromatographic column: octadecylsilane chemically bonded silica gel column
Mobile phase: the method comprises the following steps of (1) preparing a mobile phase A and a mobile phase B, wherein the mobile phase A is an ammonium formate buffer solution, and the pH value of the mobile phase A is adjusted to 2.5-3.5 by trifluoroacetic acid; the mobile phase B is methanol or/and acetonitrile; the elution procedure was followed with a gradient of 0-50 min:
Figure BDA0003039701220000032
according to this method, TBS4-Z5 and TBS3 can be retained and separated by the method of the present invention as long as the test sample contains both TBS4-Z5 and TBS3 compounds.
Drawings
FIG. 1 shows the substance verification-system applicability of terbutaline sulfate, as shown in FIG. 1, under the condition of ensuring good separation degree of main components and each impurity, the impurities TBS4-Z5 are effectively retained, and the separation degree is good
FIG. 2 chromatogram of comparative example 1
FIG. 3 chromatogram of comparative example 2
Detailed Description
The methanol used in the examples of the present invention was chromatographically pure, and the remaining reagents were analytically pure, unless otherwise indicated.
1. Instruments and reagents
The instrument comprises: thermo U3000 liquid chromatograph (with DAD detector); agilent 1260 II liquid chromatograph (with DAD detector); one part per million electronic balance (Mettler Toledo XPR 10); one-tenth-ten-thousandth electronic balance (XS 205DU, ME 204); PH meter (Mettler FE 28)
Reagent: ammonium formate, trifluoroacetic acid, methanol and water
2. Reference substance
Terbutaline sulfate reference substance (purity 99.8%, china institute for food and drug testing)
TBS3 and TBS4-Z5 controls were provided and standardized by Kyokuwa Teddy pharmaceutical Co., ltd, and the purities were 98.5% and 99.2%, respectively.
Example 1
Chromatographic conditions are as follows:
a chromatographic column: YMC Pack ODS-AQ,4.6 mm. Times.250mm, 5 μm
A mobile phase A:0.05mol/L ammonium formate buffer (pH adjusted to 3.0 with trifluoroacetic acid);
mobile phase B: methanol
Flow rate: 1.0ml/min; sample introduction amount: 20 mu l of the mixture; column temperature: at 40 ℃; detection wavelength: 276nm;
gradient elution procedure:
Figure BDA0003039701220000041
note: a Ghost peak trap column (Welch Ghost-Buster 4.6 x 50mm or Ghost peak trap column with equivalent performance) was connected in front of the active valve
1 System suitability survey
Terbutaline sulfate and appropriate amount of each impurity control were precisely weighed, dissolved and diluted with a diluent [ methanol-water (20) ], to prepare 1ml of magnesium mixed solution containing terbutaline sulfate at concentration of 1mg, TBS4-Z5, and TBS3 at concentration of 1.5 μ g, and analyzed by HPLC under the above chromatographic conditions, and the results of system applicability test are shown in table 1, as shown in fig. 1.
TABLE 1 results of the detection of the specificity of the relevant substances
Name of impurity RT(min) Degree of separation
TBS4-Z5 5.720 33.9
Terbutaline (main peak) 26.757 50.5
TBS3 48.347 N/A
As can be seen from Table 1 and FIG. 1, in the method of the present invention, TBS4-Z5, which is a highly polar impurity, is effectively retained on the chromatographic column, TBS3, which is a less polar impurity, is effectively eluted, and the applicability of the system is satisfactory.
2 specificity of degradation
Degradation solutions were prepared as in table 2.
TABLE 2 preparation of terbutaline sulfate degradation solution
Figure BDA0003039701220000051
Under each degradation condition, blank solvents and the like do not interfere with the detection of related substances of the product. The purity of the main peak is more than 990, the minimum separation degree between the impurities and the main components is 3.9, and the degradation recovery rate is between 99.00 and 103.08 percent, which all meet the requirements. The method of the invention can meet the monitoring of related substances under various degradation conditions.
The system applicability and the degradation specificity are integrated, so that the detection method for the terbutaline sulfate related substances is good in specificity, and a foundation is laid for accurate quantitative analysis of each impurity.
3 confirmation of sensitivity
Precisely weighing a proper amount of each impurity reference substance, adding a diluent to dissolve the impurity reference substance, and continuously diluting until the S/N is more than 10, namely the quantitative limit of each impurity.
Experiments show that each impurity can be accurately quantified above about 0.02%, the repeatability of the quantitative limit is good, and the sensitivity of the method is high.
4 durability
The method of the invention has the advantages that when the flow rate changes by 0.1ml/min, the column temperature changes by 2 ℃, the pH value of the buffer solution changes by 0.2, and under the condition of changing different instruments and chromatographic columns, the durability test is carried out by detecting related substances of the solution of the added standard test sample, so that the durability result is good. The specific results are shown in Table 3.
TABLE 3 durability test results (%)
Figure BDA0003039701220000061
The detection method can be used for detecting degradation impurities of the terbutaline sulfate and process impurities brought in the terbutaline sulfate synthesis process; can separate chromatographic peaks of terbutaline sulfate related substances and has good chromatographic peak separation degree.
Comparative example 1: USP43 related substance analysis method
Chromatographic conditions
A chromatographic column: zinshengtang CAPCELL PAK C18 (4.6X 150mm,5 μm);
mobile phase: mixing the ion pair solution with methanol at a ratio of 77:23, filtering, and degassing. [ ion pair solution: weighing 3.15g of ammonium formate, placing the ammonium formate in a 1000ml measuring flask, adding 900ml of water to dissolve the ammonium formate, adjusting the pH value to 3.0 by using formic acid, adding 5.49g of sodium hexanesulfonate, diluting the ammonium formate to a scale by using water, and shaking up ];
column temperature: 30 ℃; flow rate: 1.0ml/min; detection wavelength: 276nm; sample introduction volume: 20 μ l.
HPLC analysis:
the sample system applicability solution was injected under the chromatographic conditions described above.
As a result:
as shown in FIG. 2, TBS3 could not be separated by elution, with no impurities TBS4-Z5 remaining.
Comparative example 2: changing pharmacopoeia isocratic elution into gradient elution
Chromatographic conditions are as follows:
and (3) chromatographic column: thermo Scientific Hypersil GOLD C18,4.6 x 100mm,3 μm
Mobile phase A: pH3.0 buffer (4.23 g sodium hexane sulfonate and 3.15g ammonium formate, adding water 900ml to dissolve, adjusting pH to 3.0 with 10% phosphoric acid, adding water to 4000ml, to get the final product.)
And (3) mobile phase B: methanol
Detection wavelength: 276nm; column temperature: 45 ℃; flow rate: 1.0ml/min; sample introduction amount: 20 μ l
Gradient elution procedure:
Figure BDA0003039701220000062
Figure BDA0003039701220000071
as a result:
as shown in FIG. 3, TBS3 was not separated from TBS4-Z5 as impurities.

Claims (10)

1. A method for detecting related substances in terbutaline sulfate, which is characterized by comprising the following steps: the related substances at least comprise TBS4-Z5:
Figure DEST_PATH_IMAGE001
the detection is carried out by adopting high performance liquid chromatography, which comprises the following steps:
a chromatographic column: octadecylsilane chemically bonded silica gel column
Mobile phase: the method comprises the following steps of (1) preparing a mobile phase A and a mobile phase B, wherein the mobile phase A is an ammonium formate buffer solution, and the pH value is adjusted to 2.5-3.5; the mobile phase B is methanol or/and acetonitrile; the elution procedure was followed with a gradient from 0 to 50 minutes as follows:
Figure 151959DEST_PATH_IMAGE002
2. the method of claim 1, wherein: the content of ammonium formate in the buffer solution is 0.02 mol/L-0.08 mol/L.
3. The method of claim 1, wherein: the content of ammonium formate in the buffer solution is 0.04 mol/L-0.06 mol/L.
4. The method of claim 1, wherein: the pH is selected from 2.8-3.2.
5. The method according to claim 1 or 4, characterized in that: trifluoroacetic acid was used to adjust the pH.
6. The method of claim 1, wherein: the column temperature is 35-45 ℃.
7. The method of claim 1, wherein: the flow rate of the mobile phase is 0.8-1.2ml/min.
8. The method of claim 1, wherein: detection wavelength: 210-400 nm.
9. The method of claim 1, wherein: the related substances include compounds of the following structures:
Figure DEST_PATH_IMAGE003
10. a method for simultaneously detecting two compounds, comprising: the two compounds have the structural formula:
Figure 803520DEST_PATH_IMAGE004
the detection is carried out by adopting high performance liquid chromatography, which comprises the following steps:
a chromatographic column: octadecylsilane chemically bonded silica gel column
Mobile phase: the method comprises the following steps of (1) preparing a mobile phase A and a mobile phase B, wherein the mobile phase A is an ammonium formate buffer solution, and the pH value of the mobile phase A is adjusted to 2.5-3.5 by trifluoroacetic acid; the mobile phase B is methanol or/and acetonitrile; the elution procedure was followed with a gradient of 0-50 min:
Figure DEST_PATH_IMAGE005
。/>
CN202110453648.4A 2021-04-26 2021-04-26 Method for detecting related substances in terbutaline sulfate Active CN113189228B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110453648.4A CN113189228B (en) 2021-04-26 2021-04-26 Method for detecting related substances in terbutaline sulfate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110453648.4A CN113189228B (en) 2021-04-26 2021-04-26 Method for detecting related substances in terbutaline sulfate

Publications (2)

Publication Number Publication Date
CN113189228A CN113189228A (en) 2021-07-30
CN113189228B true CN113189228B (en) 2023-04-07

Family

ID=76979410

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110453648.4A Active CN113189228B (en) 2021-04-26 2021-04-26 Method for detecting related substances in terbutaline sulfate

Country Status (1)

Country Link
CN (1) CN113189228B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114460217B (en) * 2022-01-29 2023-06-30 杭州沐源生物医药科技有限公司 Method for separating and detecting terbutaline sulfate injection and impurities thereof
CN114674951B (en) * 2022-03-23 2023-03-24 广东金城金素制药有限公司 Method for detecting terbutaline sulfate injection and related substances

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110057932B (en) * 2019-04-22 2022-03-15 上海旭东海普药业有限公司 Method for analyzing terbutaline sulfate related substances by high performance liquid chromatography
CN110118842A (en) * 2019-06-11 2019-08-13 南京华盖制药有限公司 The method for measuring EDTA-2Na content in terbutaline sulfate solution

Also Published As

Publication number Publication date
CN113189228A (en) 2021-07-30

Similar Documents

Publication Publication Date Title
US11187683B2 (en) Dexrazoxane analytical method
CN113189228B (en) Method for detecting related substances in terbutaline sulfate
WO2021227233A1 (en) Method for detecting two photodegradable impurities in moxifloxacin hydrochloride raw material and preparation
CN109470799A (en) The purity and impurity position finding and detection method of Fmoc-Arg (Pbf)-OH
Lopes et al. Quantification of carbamazepine and its active metabolite by direct injection of human milk serum using liquid chromatography tandem ion trap mass spectrometry
CN107315059B (en) The content assaying method of rifampin and its impurity in a kind of rifampicin capsules
CN113804792B (en) Method for detecting related substances of 5-p-nitrophenylfurfural
CN112630365B (en) Method for determining content of dimyristoyl phosphatidylcholine by high performance liquid chromatography
CN111624275A (en) Method for measuring related substances of compound ipratropium bromide solution for inhalation by high performance liquid chromatography
CN113820417B (en) Method for separating and measuring piroxicam and impurities thereof
CN113466392B (en) Method for detecting dexrazoxane and related substances thereof
CN112034066B (en) Method for separating and measuring Ribociclib and impurities
Alvinerie et al. Simultaneous determination of albendazole and its principal metabolites in plasma by normal phase high-performance liquid chromatography
CN112798702B (en) Method for detecting related substances in dexmedetomidine hydrochloride raw material or preparation
CN111812240B (en) Separation method and application of oxytocin and three impurities
CN110412164B (en) Method for detecting related substances of mexiletine hydrochloride
CN111007181A (en) Method for detecting isosorbide mononitrate
CN114674951B (en) Method for detecting terbutaline sulfate injection and related substances
CN111896642B (en) Separation method and application of oxytocin and three kinds of deamidation impurities
CN114224904B (en) Clindamycin phosphate and quality control method
CN115327004B (en) Method for detecting clopidogrel oxide crude product
CN111579653B (en) Method for detecting related substances of fluconazole
CN117571905A (en) Detection and analysis method for cimetidine intermediate
CN117871727A (en) Method for detecting citrate content in linezolid glucose injection
CN117434196A (en) Quality control method of vitamin A

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant